Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 21;8(2):ofab034.
doi: 10.1093/ofid/ofab034. eCollection 2021 Feb.

Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases

Affiliations

Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases

Jean Claude S Ngabonziza et al. Open Forum Infect Dis. .

Abstract

We report 2 cases for whom Xpert MTB/RIF falsely signaled rifampicin-resistant tuberculosis, based on unusually low cycle threshold and 3 of 5 probes missing. Other mycobacterial tests were negative. Further optimization of the Xpert MTB/RIF algorithm is warranted.

Keywords: Xpert MTB/RIF assay; active case finding; false detection of TB; rifampicin resistance.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
False signals for detection of tuberculosis (TB) and/or rifampicin resistance results. (A) Test report of false TB detection showing low probe cycle threshold (Ct) values and jagged amplification curves. (B) Test report of false TB detection showing low probe Ct values and straight lines instead of standard polymerase chain reaction amplification curves. (C) Test report of false rifampicin resistance showing low probe Ct values and amplification curves. (D) Test report of false rifampicin resistance showing a low Ct value for probe E.
Figure 1.
Figure 1.
False signals for detection of tuberculosis (TB) and/or rifampicin resistance results. (A) Test report of false TB detection showing low probe cycle threshold (Ct) values and jagged amplification curves. (B) Test report of false TB detection showing low probe Ct values and straight lines instead of standard polymerase chain reaction amplification curves. (C) Test report of false rifampicin resistance showing low probe Ct values and amplification curves. (D) Test report of false rifampicin resistance showing a low Ct value for probe E.

References

    1. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005–15. - PMC - PubMed
    1. Albert H, Nathavitharana RR, Isaacs C, et al. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J 2016; 48:516–25. - PMC - PubMed
    1. Ngabonziza JS, Habimana YM, Decroo T, et al. Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda. Int J Tuberc Lung Dis 2020; 24:329–39. - PubMed
    1. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647–50. - PubMed
    1. Ngabonziza JCS, Decroo T, Migambi P, et al. Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda. The Lancet Microbe 2020; 1:e74–83. - PubMed